Viewing Study NCT02501161


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-01-14 @ 8:15 PM
Study NCT ID: NCT02501161
Status: COMPLETED
Last Update Posted: 2019-11-27
First Post: 2015-07-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN9068-4228
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators